August 1, 2014

European Inter-Institutional Impact Study of MammaPrint

PUBLICATION: 
The Breast August 2014, Volume 23, Issue 4, Pages 423–428

AUTHORS: 
P.G. Cusumano, D. Generali, E. Ciruelos, L. Manso, I. Ghanem, E. Lifrange, G. Jerusalem, J. Klaase, F. de Snoo, L. Stork-Sloots, L. Dekker-Vroling, M. Lutke Holzik

SUMMARY: 
Using MammaPrint, chemotherapy treatment advice for ER+/HER2- breast cancer patients was changed in 37% of patients by the Dutch, 24% by the Belgian, 28% by the Italian and 35% by the Spanish teams. MammaPrint increased the inter-institutional agreement in treatment advice (chemotherapy or no chemotherapy) from 51% to 75%.

Read more: European Inter-Institutional Impact…Cusumano et al_The Breast 2014